Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
Plos Medicine|September 21, 2019
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)Catriona Waitt, Catherine Orrell, Stephen Walimbwa, et al.
The Journal of Antimicrobial Chemotherapy|July 12, 2024
Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan AfricaDaniel Kiiza, Danial Rostami-Hochaghan, Yussif Alhassan, et al.
The Lancet. HIV|September 24, 2016
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessmentIan McGowan, Charlene S Dezzutti, Aaron Siegel, et al.
Clinical Pharmacology and Therapeutics|February 18, 2026
Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to AccessUsman Arshad, Lobna Gaayeb, Henry Pertinez, et al.
HIV Medicine|October 2, 2008
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008B G Gazzard, Jane Anderson, Abdel Babiker, et al.
AIDS (London, England)|November 22, 2024
SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in AfricaEmmanuelle Papot, Tamara Tovar-Sanchez, Joana Woods, et al.
The Lancet. HIV|July 29, 2022
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled studyThokozile R Malaba, Irene Nakatudde, Kenneth Kintu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 27, 2018
Two cases of monkeypox imported to the United Kingdom, September 2018Aisling Vaughan, Emma Aarons, John Astbury, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2017
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected populationDaniel F Carr, Stephane Bourgeois, Mas Chaponda, et al.
Ebiomedicine|June 16, 2023
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trialCarolina Herrera, Jennifer Serwanga, Laura Else, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Plos Medicine|September 21, 2019
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)Catriona Waitt, Catherine Orrell, Stephen Walimbwa, et al.
The Journal of Antimicrobial Chemotherapy|July 12, 2024
Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan AfricaDaniel Kiiza, Danial Rostami-Hochaghan, Yussif Alhassan, et al.
The Lancet. HIV|September 24, 2016
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessmentIan McGowan, Charlene S Dezzutti, Aaron Siegel, et al.
Clinical Pharmacology and Therapeutics|February 18, 2026
Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to AccessUsman Arshad, Lobna Gaayeb, Henry Pertinez, et al.
HIV Medicine|October 2, 2008
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008B G Gazzard, Jane Anderson, Abdel Babiker, et al.
AIDS (London, England)|November 22, 2024
SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in AfricaEmmanuelle Papot, Tamara Tovar-Sanchez, Joana Woods, et al.
The Lancet. HIV|July 29, 2022
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled studyThokozile R Malaba, Irene Nakatudde, Kenneth Kintu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 27, 2018
Two cases of monkeypox imported to the United Kingdom, September 2018Aisling Vaughan, Emma Aarons, John Astbury, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2017
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected populationDaniel F Carr, Stephane Bourgeois, Mas Chaponda, et al.
Ebiomedicine|June 16, 2023
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trialCarolina Herrera, Jennifer Serwanga, Laura Else, et al.
Pageof 29